Abstract
The indigenous oral microflora and the host are normally in a state of equilibrium; however, the introduction of a pathogen can result in innate and adaptive immune responses that either contribute to the development of the disease or lead to host immunity. The interactions between the microorganisms and the host are very dynamic, thus allowing the complex interplay between host molecules and bacterial antigens. In this article, we focus on the mechanisms involved in the pathogenesis of and host responses to two oral pathogens: the Gram-negative bacterium Porphyromonas gingivalis, implicated in the etiology of periodontal disease, and the Gram-positive Streptococcus mutans, a primary agent involved in dental caries formation. Furthermore, we address mechanisms involved in the ability of select adjuvants and delivery systems to potentiate mucosal and systemic immune responses to microbial vaccine antigens.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Takeda K, Akira S: Roles of Toll-like receptors in innate immune responses. Genes Cells 2001;6: 733–742.
Duncan MJ, Emory SA, Almira EC: Porphyromonas gingiralis genes isolated by screening for epithelial cell attachment. Infect Immun 1996;64:3624–3631.
Lamont RJ, Chan A, Belton CM, Izutsu KT, Vasel D, Weinberg A: Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun 1995;63:3878–3885.
Katz J, Sambandam V, Wu JH, Michalek SM, Balkovetz DF: Characterization of Porphyromonas gingivalis-induced degradation of epithelial cell junctional complexes. Infect Immun 2000; 68:1441–1449.
Katz J, Yang Q-B, Zhang P, Potempa J, Travis J, Michaels SM, Balkovetz DF: Hydrolysis of epithelial junctional proteins by Porphyromonas gingivalis gingipains. Infect Immun 2002;70: 2512–2518.
Holt SC, Kesavalu L, Walker S, Genco CA: Virulence factors of Porphyromonas gingivalis. Periodontology 2000 1999;20:168–238.
Katz J, Ward DC, Michalek SM: Effect of host responses on the pathogenicity of strains of Porphyromonas gingivalis. Oral Microbiol Immunol 1996;5: 309–318.
Katz J, Black KP, Michalek SM: Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model. Infect Immun 1999;67:4352–4359.
Kohler JJ, Pathangey LB, Brown TA: Oral immunization with recombinant Salmonella typhimurium expressing a cloned Porphyromonas gingivalishemagglutinin: effect of boosting on mucosal, systemic and immunoglobulin G subclass response. Oral Microbiol Immunol 1998;13: 81–88.
Yang Q-B, Lamberty L, Michalek SM, Katz J: Monophosphoryl lipid A enhances responses to hemagglutinin B of Porphyromonas gingivalis. J Dent Res 2001;80:123.
Medzhitov R, Preston-Hurlburt P, Janeway CA: A human homologue of the Drosophilar Toll protein signals activation of adaptive immunity. Nature 1997;388:394–397.
Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ: Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998;395:284–288.
Zahringer U, Lindner B, Rietschel ET: Chemical structure of lipid A: recentadvances in structural analysis of biologically active molecules; in Brade H, Opal SM, Vogel SN, Morrison DC (eds): Endotoxin in Health and Disease. New York, Marcel Dekker, 1999 pp 93–114.
Means TK, Wang S, Lien E, Yushimura A, Golenbock DT, Fenton MJ: Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999;163:3920–3927.
Hirschfeld M, Weis JJ, Toshchakov V, Salkowski CA, Cody MJ, Ward DC, Qureshi N, Michalek SM, Vogel SN: Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 21;69:1477–1482.
Martin M, Katz J, Vogel SN, Michalek SM: Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J Immunol 2001; 167:5278–5285.
Schade FU, Flash R, Flohe S, Majetschak M, Kreuzfelder K, Dominguez-Fernandez E, Borgermann J, Reuter M, Obertacke U: Endotoxin tolerance; in Brade H, Opal SM, Vogel S, Morrison DC (eds): Endotoxin in Health and Disease. New York, Marcel Dekker, 1999, pp 751–767.
Kraatz J, Clair L, Rodriguez JL, West MA: In vitro macrophage endotoxin tolerance: defective in vitro macrophage map kinese signal transduction after LPS pretreatment is not present in macrophages from C3H/HeJ endotoxin resistant mice. Shock 1999;11:58–63.
Medvedev AE, Kopydlowski KM, Vogel SN: Inhibition of lipopolysaccharide-induced signal transduction in endotoxintolerized mouse macrophages: dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression J Immunol 2000;164:5564–5574.
Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, Nakanishi K, Kimoto M, Miyake K, Takeda K, Akira S: Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. J Immunol 2000;164:3476–3479.
Hajishengallis G, Michalek SM: Current status of a mucosal vacine against dental caries. Oral Microbiol Immunol 1999;14: 1–20.
Russel MW, Hajishengallis G, Childers NK, Michalek SM: Secretory immunity in defense against cariogenic mutants streptococci. Caries Res 1999;33:4–15.
Michalek SM, Katz J, Childers NK: A vaccine against dental caries. Bio Drugs 2001;15: 501–508.
Zhang P, Jespersgaard C, Lamberty L, Huang Y, Katz J, Michalek SM: Immunization with the genetic chimeric protein SBR-GLU results in augmented immune responses. J Dent Res 2001;80:123.
Ulrich JT, Myers KR: Monophosphoryl lipid A as an adjuvant: past experiences and new directions; in Powell MF, Newman MJ (eds): Vaccine Design: The Subunit and Adjuvant Approach. New York, Plenum, 1995, pp. 495–524.
Childers NK, Miller KL, Tong G, Llarena JC, Greenway T, Ulrich JT, Michalek SM: Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen Infect Immun 2000;68: 5509–5516.
Michalek SM, Childers NK, Greenway T, Hajishengallis G, Ulrich JT: Monophosphoryl lipid A: an effective adjuvant for potentiating mucosal immune responses. J Endotoxin Res 1999;5:181–182.
Moore A, McCarthy L, Mills KGH: The adjuvant combination of monophosphory lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1. Vaccine 1999;17:2517–2527.
Salkowski CA, Delore GR, Vogel SN: Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma interferon, and IL-10 mRNA production in mouse macrophages. Infect Immun 1997;65:3239–3247.
De Becker G, Moulin V, Pajak B, Bruck C, Francotle M, Thiriart C, Urbain J, Moser M: The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells. Int Immunol 2000;12: 807–815.
Elson CO, Dertzbaugh MT: Mucosal adjuvants; in Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR (eds): Mucosal Immunology. San Diego, Academic, 1999, pp. 817–838.
Martin M, Metzger DJ, Michalek SM, Connell TD, Russell MW: Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb. Infect Immun 2000; 68:281–287.
Martin M, Metzger DJ, Michalek SM, Connell TD, Russell MW: Distinct cytokine regulation by choleratoxin and type II heat-labile toxins involved differential regulation of CD40 ligand on CD4+ T cells Infect Immun 2001;69: 4486–4492.
Martin M, Hajishengallis G, Metzger DJ, Michalek SM, Connell TD, Russell MW: Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4+T cell Infect Immun 2001; 69:252–261.
Hajishengallis G, Hollingshead SK, Koga T, Russell MW: Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J Immunol 1995;154:4322–4332.
Harokorpakis E, Hajishengallis G, Greenway TE, Russell MW, Michalek SM: Mucosal immunogenicity of a recombinant Salmonella typhiumurium-cloned heterologous antigen in the absenceorpresence of coexpressed cholera toxin A2 and B subunits. Infect Immun 1997;65:1445–1454.
Huang Y, Hajishengallis G, Michalek SM: Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar Typhimurium expressing a S. mutans adhesin under the control of the in vivo-inducible nirB promoter. Infect Immun 2001;69: 2154–2161.
Hanokopakis E, Hajishengallis G, Michalek SM: Effectiveness of liposomes possessing surfacelinked recombinant B subunit of cholera toxin as an oral antigen delivery system Infect Immun 1998;66:4299–4304.
VanCott JL, Staats HF, Pascual DW, Roberts M, Chatfield SN, Yamamoto M, Coste M, Carter PB, Kiyomo H, McGhee JR: Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with liver recombinant Salmonella. J Immunol 1996;156: 1504–1514.
Pascual DW, Hone DM, Hall S, van Ginkel FW, Yamamoto M, Walters N, Fujihashi K, Powell RJ, Wu S, VanCott JL, Kiyono H, McGhee JR: Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen 1 by Salmonella typhimurium elicits a biphasic T helper cell response. Infect Immun 1999;67:6249–6256.
Smith DJ, King WF, Taubman MA: Salivary IgA antibody to oral streptococcal antigens in predentate infants. Oral Microbiol Immunol 1990;5:57–62.
Caufield PW, Cutter GR, Dasanayake AP: Initial acquisition of mutans streptococci by infants: evidence for a discrete window of infectivity. J Dent Res 1993;72: 37–45.
Czerkinsky C, Prince SJ, Michalek SM, Jackson S, Russell MW, Moldoveanu Z, McGhee JR, Mestecky J: IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc. Natl Acad Sci USA 1987;84: 2449–2453.
Mestecky J, McGhee JR, Arnold RR, Michalek SM, Prince SJ, Babb JL: Selective induction of an immune response in human external secretions by ingestions of bacterial antigen. J Clin Invest 1978;61:731–737.
Michalek SM, O'Hagan DT, Gould-Fogerite S, Osterhaus ADME, Rimmelzwaan GF: Antigen delivery systems I. Non-living microparticles, liposomes, cochleates, and iscoms; in Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR (eds): Mucosal Immunology. New York, Academic, 1999, pp 759–778.
Childers NK, Tong G, Mitchell S, Kirk K, Russell MW, Michalek SM: A controlled clinical study of the effect of nasal immunization with a Streptococcus mutans antigenaloneo rincorporated liposomes on induction of immune responses Infect Immun 1999;67: 618–623.
Childers NK, Tong G, Li F, Dasanayake AP, Kirk K, Michalek SM: Humans immunized with Streptococcus mutants antigens by the mucosal routes. J Dent Res 2001;81:48–52.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Michalek, S.M., Katz, J., Childers, N.K. et al. Microbial/host interactions. Immunol Res 26, 223–234 (2002). https://doi.org/10.1385/IR:26:1-3:223
Issue Date:
DOI: https://doi.org/10.1385/IR:26:1-3:223